Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: February 2013
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Bowman v. Monsanto: The U.S. Supreme Court Hearing" on February 22, 2013 beginning at 1:00 pm (ET). A panel consisting of Prof. Shubha Ghosh of the University of Wisconsin Law School, Patent Docs author Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP,…
-
The Biotechnology Industry Organization (BIO) will be holding its 2013 Spring Intellectual Property Counsels Committee (IPCC) Conference on March 25-27, 2013 in San Diego, CA. The semi-annual IPCC conference will once again be open to the public. The conference will offer presentations on the following topics: Monday, March 25: • Effecting and Managing Change (Pre-Conference…
-
By Kevin E. Noonan — Whether ANDA litigation has had a positive or negative impact on generic drug availability is an open question, in view of several recent reports looking at the effects such litigation has had on both branded and generic drugs over the past thirty years. Indeed, the current squabble over "reverse payment"…
-
By Donald Zuhn — In a press release issued earlier today, the U.S. Patent and Trademark Office announced that examination guidelines and the final rule for implementing the first-inventor-to-file (FITF) provisions of the Leahy-Smith America Invents Act (AIA) would be published in the Federal Register on February 14 — thirty days before the FITF provisions…
-
By Donald Zuhn — In an amicus brief filed last month in Association for Molecular Pathology v. Myriad Genetics, Inc., the United States asks the Supreme Court to affirm the judgment of the Federal Circuit that cDNA is patent-eligible and reverse the judgment of the appellate court that isolated but otherwise unmodified DNA is patent-eligible. The…
-
By Donald Zuhn — In December, the U.S. Patent and Trademark Office published a notice in the Federal Register (77 Fed. Reg. 72830) seeking public feedback on Request for Continued Examination (RCE) practice. The notice provided a series of questions for which the Office specifically was seeking comment: (1) If within your practice you file…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Cadence Pharmaceuticals, Inc. et al. v. Sandoz Inc.3:13-cv-00733; filed February 5, 2013 in the District Court of New Jersey • Plaintiffs: Cadence Pharmaceuticals, Inc.; SCR Pharmatop• Defendant: Sandoz Inc. Cadence Pharmaceuticals, Inc. et al. v.…
-
February 13, 2013 – Corporate Intellectual Property Law Conference (Law Bulletin Publishing Company) – Chicago, IL February 14, 2013 – Last Chance! The Top Ten Things In-House Counsel Need to Do to Prepare for The AIA’s March 2013 Deadline (McDonnell Boehnen Hulbert & Berghoff LLP) – 10:00 am to 11:15 am (CST) February 20, 2013…
-
McDonnell Boehnen Hulbert & Berghoff LLP will be offering a live webinar on "Improving the Success of Appeals to the Patent Trial and Appeal Board" on March 20, 2013 from 10:00 am to 11:15 am (CT). MBHB attorney Blair Hughes will provide tools that will help attendees improve their appeal success by: (1) better evaluating…
-
Strafford will be offering a webinar/teleconference entitled "Patent Inventorship: Best Practices for Determination and Correction" on March 7, 2013 from 1:00 – 2:30 pm (EST). Thomas L. Irving of Finnegan Henderson Farabow Garrett & Dunner and Lauren L. Stevens of Foley & Lardner will provide guidance for patent counsel on identifying and determining inventorship and…
Patent Docs 